- US-listed companies
- RESMED INC
- Cash flow
RESMED INC【RMD】Cash flow
Market cap
$37B
P/E ratio
| 2011/06 | 2012/06 | 2013/06 | 2014/06 | 2015/06 | 2016/06 | 2017/06 | 2018/06 | 2019/06 | 2020/06 | 2021/06 | 2022/06 | 2023/06 | 2024/06 | 2025/06 | |
| Depreciation & amortization | 71 | 86 | 78 | 73 | 73 | 87 | 112 | 120 | 151 | 155 | 157 | 160 | 165 | 177 | 198 |
| Stock-based compensation | 31 | 31 | 38 | 43 | 48 | 46 | 46 | 48 | 52 | 58 | 64 | 65 | 71 | 80 | 92 |
| Cash from operations | 283 | 383 | 403 | 391 | 383 | 548 | 414 | 505 | 459 | 802 | 737 | 351 | 693 | 1,401 | 1,752 |
| Capital expenditures | -67 | -47 | -64 | -73 | -63 | -59 | -62 | -63 | -69 | -95 | -103 | -135 | -120 | -99 | -90 |
| Cash from investing | -77 | -102 | -78 | -95 | -143 | -1,126 | -82 | -102 | -1,076 | -180 | -158 | -230 | -1,160 | -270 | -200 |
| Payments for dividends | - | - | 97 | 142 | 157 | 168 | 186 | 199 | 212 | 225 | 227 | 245 | 258 | 282 | 311 |
| Repurchases of common stock | 163 | 393 | 186 | 202 | 160 | 102 | - | 54 | 23 | - | - | - | - | 150 | 300 |
| Proceeds from issuance of term debt, net | 98 | 270 | 150 | 558 | 180 | 1,140 | 450 | 350 | 1,519 | 1,190 | 90 | 288 | 1,070 | 105 | - |
| Repayments of term debt | 124 | 126 | 100 | 560 | 182 | 284 | 545 | 1,146 | 712 | 1,284 | 612 | 166 | 405 | 835 | 40 |
| Cash from financing | -79 | -177 | -154 | -297 | -256 | 613 | -263 | -1,027 | 581 | -317 | -765 | -128 | 423 | -1,119 | -606 |
| Free cash flow | |||||||||||||||
| FCF margin (%) |